Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Buy
51
ACTU Quote, Financials, Valuation and Earnings
Last price:
$7.34
Seasonality move
:
-23.17%
Day range:
$7.30 - $7.64
52-week range:
$5.47 - $11.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
15.62x
Volume:
57.1K
Avg. volume:
52.1K
1-year change:
-16.1%
Market cap:
$170.8M
Revenue:
--
EPS (TTM):
-$1.21
Earnings Data
Next earnings date for ACTU
Mar 31
2026
Most recent earnings per share
-$0.25
Beat by $0.02
(Nov 13/2025)
Consensus Estimate
-$0.28
(Nov 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ACTU Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q4 | -- | -- | -- | -$0.25 | -- |
| 11/13/2025 | Q3 | -- | -- | -$0.25 | -$0.28 | $0.02 |
| 08/29/2025 | Q2 | -- | -- | -$0.30 | -$0.32 | $0.01 |
| 05/15/2025 | Q1 | -- | -- | -$0.32 | -$0.30 | -$0.02 |
| 03/14/2025 | Q4 | -- | -- | -$0.33 | -$0.29 | -$0.04 |
| 11/13/2024 | Q3 | -- | -- | -$0.31 | -- | -- |
| 06/30/2024 | Q2 | -- | -- | -$0.34 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.43 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.40 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.32 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.28 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.28 | -- | -- |
Actuate Therapeutics, Inc. Earnings Questions
-
How Much did Actuate Therapeutics, Inc. Generate in Revenue Last Quarter?
Actuate Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Actuate Therapeutics, Inc. Beat Earnings Last Quarter?
Actuate Therapeutics, Inc. announced earnings per share of -$0.25 which represents a beat of analyst forecast a -$0.28 per share.
-
Is Actuate Therapeutics, Inc. Profitable?
Actuate Therapeutics, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Actuate Therapeutics, Inc. EPS Next Year?
Actuate Therapeutics, Inc.'s earnings are forecast to decrease from -$1.40 per share to -$3.16 per share next year representing a decrease of -22.45%.
-
When is Actuate Therapeutics, Inc.'s Earnings Date?
Actuate Therapeutics, Inc.'s next earnings date is March 31, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
